According to AZ, SERENA-6 is also the first pivotal trial to show the value of measuring circulating tumour DNA (ctDNA) to detect ESR1 status and treat emerging resistance, although routine use of ...

Our expert, award-winning staff selects the products we cover and rigorously researches and tests our top picks. If you buy through our links, we may get a commission. Attila covers software, apps ...

🏨 Hotel Del’s makeover 🚗 Carlsbad traffic circles ⚾ SDSU’s new coach 🛍️ Westfield UTC update 🌭 Top 10 best fair foods Developer Stockdale Capital Partners says the receivership ...